Navigating the post-COVID-19 immunological era: understanding long COVID-19 and immune response

A Mohan, VA Iyer, D Kumar, L Batra, P Dahiya - Life, 2023 - mdpi.com
The COVID-19 pandemic has affected the world unprecedentedly, with both positive and
negative impacts. COVID-19 significantly impacted the immune system, and understanding …

Multi-faceted dysregulated immune response for COVID-19 infection explaining clinical heterogeneity

SK Paine, P Choudhury, M Alam, C Bhattacharyya… - Cytokine, 2024 - Elsevier
Clinical heterogeneity and varied prognosis are well noted for SARS-CoV-2 infection.
Altered immune response is a major feature for the adverse prognosis however focus on …

Innate immune response to SARS-CoV-2 infection: From cells to soluble mediators

D Ricci, MP Etna, F Rizzo, S Sandini, M Severa… - International journal of …, 2021 - mdpi.com
The vulnerability of humankind to SARS-CoV-2 in the absence of a pre-existing immunity,
the unpredictability of the infection outcome, and the high transmissibility, broad tissue …

Protective and pathogenic role of humoral responses in COVID-19

U Park, NH Cho - Journal of Microbiology, 2022 - Springer
Since the advent of SARS-CoV-2 in Dec. 2019, the global endeavor to identify the
pathogenic mechanism of COVID-19 has been ongoing. Although humoral immunity …

Immune-profiling of SARS-CoV-2 viremic patients reveals dysregulated innate immune responses

X Sun, C Gao, K Zhao, Y Yang, Y Rassadkina… - Frontiers in …, 2022 - frontiersin.org
SARS-CoV-2 plasma viremia has been associated with severe disease and death in COVID-
19. However, the effects of viremia on immune responses in blood cells remain unclear. The …

Cell-mediated immune responses to COVID-19 infection

A Guihot, E Litvinova, B Autran, P Debré… - Frontiers in …, 2020 - frontiersin.org
An unprecedented outbreak of pneumonia caused by a novel coronavirus (CoV),
subsequently termed COVID-19 by the World Health Organization, emerged in Wuhan City …

Immunological perspectives on the pathogenesis, diagnosis, prevention and treatment of COVID-19

Y Ni, A Alu, H Lei, Y Wang, M Wu, X Wei - Molecular biomedicine, 2021 - Springer
Abstract Coronavirus disease 2019 (COVID-19) is an acute respiratory disease caused by
severe acute respiratory syndrome coronavirus 2 (SARS-COV-2). COVID-19 can spread to …

COVID-19 and immunity: quo vadis?

M Miyasaka - International Immunology, 2021 - academic.oup.com
Understanding the precise nature and durability of protective immunity against severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) is essential in order to gain insight into …

Immune responses during COVID-19 infection

C Melenotte, A Silvin, AG Goubet, I Lahmar… - …, 2020 - Taylor & Francis
Over the past 16 years, three coronaviruses (CoVs), severe acute respiratory syndrome CoV
(SARS-CoV) in 2002, Middle East respiratory syndrome CoV (MERS-CoV) in 2012 and …

Coronavirus disease 2019 (COVID-19): Immunological approaches and emerging pharmacologic treatments

P Goodarzi, F Mahdavi, R Mirzaei, H Hasanvand… - International …, 2020 - Elsevier
The SARS-CoV-2 virus is an etiological agent of pandemic COVID-19, which spreads
rapidly worldwide. No proven effective therapies currently exist for this virus, and efforts to …